Top Markets
Coin of the day
ShockWave Medical, Inc. ShockWave Medical, Inc.

ShockWave Medical, Inc.

SWAV
Rang in Aktien #1815
ShockWave Medical, Inc. is a medical technology firm that specializes in the... ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Aktienkurs
$334.75
Zuletzt synchronisiert: 2024-05-30
Marktkapitalisierung
$12.46B
Veränderung (1 Tag)
-0.02%
Veränderung (1 Jahr)
0.00%
Land
US
Handel ShockWave Medical, Inc. (SWAV)

Kategorie

EPS für ShockWave Medical, Inc. (SWAV)
EPS zum March 2024 TTM: $4.42
Laut den aktuellen Finanzberichten und dem Aktienkurs von ShockWave Medical, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $4.42. Am Ende des Jahres 2022 betrug das EPS $6.02 eine Steigerung gegenüber dem EPS von 2021, das $-0.26 betrug.
EPS-Verlauf von ShockWave Medical, Inc. von 2017 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $4.42 10.22%
2023 $4.01 -33.39%
2022 $6.02 -2,415.38%
2021 $-0.26 -86.93%
2020 $-1.99 -7.01%
2019 $-2.14 39.87%
2018 $-1.53 -2.55%
2017 $-1.57 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$3.11 -29.64%
US
$9.73 120.14%
US
$3.59 -18.78%
IE
$2.48 -43.89%
US
- -
DE